Multiple sclerosis: basic knowledge and new insights in perioperative management

被引:0
作者
Alexandros Makris
Alexandros Piperopoulos
Iosifina Karmaniolou
机构
[1] Asklepieion Hospital of Voula,Department of Anesthesiology
[2] Royal National Orthopaedic Hospital,Department of Anesthesia
来源
Journal of Anesthesia | 2014年 / 28卷
关键词
Multiple sclerosis; General anesthesia; Regional anesthesia;
D O I
暂无
中图分类号
学科分类号
摘要
Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system affecting young adults that may lead to significant disability. The clinical course varies among the types of the disease as well as among individuals. Herein we provide a brief review of the recent data concerning the clinical presentation, diagnosis, causes, and pathogenesis of MS as well as medication used, followed by the anesthetic considerations of patients diagnosed with the disease. To accomplish this, we conducted a systematic PubMed literature search for articles, using the terms multiple sclerosis, anesthesia, general, regional, perioperative, and preoperative, and we then manually reviewed the references from each pertinent article. Because randomized controlled trials on the field are rare, most information is derived by case reports and case series. We concluded that the disease itself as well as the treatment modalities may have several implications in the conduct of anesthesia and perioperative management of MS patients. General and regional anesthetic techniques have been successfully used. With thorough preoperative evaluation and in depth knowledge of the disease and its complications, the MS patients can be managed safely.
引用
收藏
页码:267 / 278
页数:11
相关论文
共 517 条
[1]  
Charcot JM(1868)Histologie de la sclerose en plaques Gazette des Hopitaux 41 554-555
[2]  
Compston A(2008)Multiple sclerosis Lancet 372 1502-1517
[3]  
Coles A(2001)The prevalence of multiple sclerosis in the world: an update Neurol Sci 22 117-139
[4]  
Rosati G(2010)The changing demographic pattern of multiple sclerosis epidemiology Lancet Neurol 9 520-532
[5]  
Koch-Henriksen N(2006)Age at disability milestones in multiple sclerosis Brain 129 595-605
[6]  
Sørensen PS(2012)Cost-effectiveness of disease-modifying therapies in multiple sclerosis Curr Neurol Neurosci Rep 12 592-600
[7]  
Confavreux C(2009)Natural history comparisons of primary and secondary progressive multiple sclerosis reveals differences and similarities J Neurol 256 374-381
[8]  
Vukusic S(2009)Symptomatology of MS: results from the German MS Registry J Neurol 256 1932-1935
[9]  
Manouchehrinia A(2012)Mechanisms underlying muscle fatigue differ between multiple sclerosis patients and controls: a combined electrophysiological and neuroimaging study Neuroimage 59 3110-3118
[10]  
Constantinescu CS(2012)Depression in multiple sclerosis: a review of assessment and treatment approaches in adult and pediatric populations ISRN Neurol 2012 427102-367